Boston Partners
PRTK

Boston Partners’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Boston Partners’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-112,143
Closed -$1.09M – 754
2018
Q3 		$1.09M Sell
112,143
-3,139
-3% -$31.7K ﹤0.01% 666
2018
Q2 		$1.18M Sell
115,282
-18,400
-14% -$208K ﹤0.01% 723
2018
Q1 		$1.74M Hold
133,682
– – ﹤0.01% 664
2017
Q4 		$2.39M Hold
133,682
– – ﹤0.01% 649
2017
Q3 		$3.35M Hold
133,682
– – ﹤0.01% 585
2017
Q2 		$3.22M Sell
133,682
-23,176
-15% -$512K ﹤0.01% 577
2017
Q1 		$3.02M Hold
156,858
– – ﹤0.01% 594
2016
Q4 		$2.42M Buy
+156,858
New +$2.04M ﹤0.01% 650

Other funds holding PRTK

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $147M AUM 99.81% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM